ACADIA Pharmaceuticals Inc.
NASDAQ: ACAD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Catherine E. Owen Adams
- Employees
- 653
- Headquarters
- San Diego, United States
- IPO year
- 2004
- Market cap
- $3.7B
- Website
- https://www.acadia-pharm.com
Loading ACAD…
Loading profile data…Frequently asked questions about ACAD
What does ACADIA Pharmaceuticals Inc. (ACAD) do?
ACADIA Pharmaceuticals Inc. operates as a biopharmaceutical company, primarily dedicated to discovering, developing, and commercializing small molecule therapeutics. Their core focus lies in addressing critical unmet medical needs within the realm of central nervous system (CNS) disorders. The company's marketed product, NUPLAZID (pimavanserin),...
Where does ACAD trade?
ACADIA Pharmaceuticals Inc. (ACAD) trades on the NASDAQ Global Select.
What sector is ACAD in?
ACADIA Pharmaceuticals Inc. (ACAD) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of ACADIA Pharmaceuticals Inc.?
Catherine E. Owen Adams is the chief executive officer of ACADIA Pharmaceuticals Inc. (ACAD).
Where is ACADIA Pharmaceuticals Inc. headquartered?
ACADIA Pharmaceuticals Inc. is headquartered in United States.
Does ACAD pay a dividend?
ACADIA Pharmaceuticals Inc. (ACAD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACAD go public?
ACADIA Pharmaceuticals Inc. (ACAD) completed its initial public offering in 2004.